Menu

Filtros : "The Lancet Microbe" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico-carta/editorial

    The emergence of tet(X) variants highlight challenges for the global genomic surveillance of tigecycline resistance (2023)

    Furlan, João Pedro Rueda ; Castillo, Danny Fuentes ; Stehling, Eliana Guedes ; Sellera, Fábio P. ; Lincopan, Nilton

    Source: The Lancet Microbe. Unidades: FCFRP, ICB, FMVZ

    Subjects: ANTIBIÓTICOS, GENÔMICA, RESISTÊNCIA MICROBIANA ÀS DROGAS, SEQUENCIAMENTO GENÉTICO, VARIAÇÃO GENÉTICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FURLAN, João Pedro Rueda et al. The emergence of tet(X) variants highlight challenges for the global genomic surveillance of tigecycline resistance. The Lancet Microbe. London: The Lancet Publishing Group. Disponível em: https://doi.org/10.1016/S2666-5247(23)00249-5. Acesso em: 27 abr. 2024. , 2023

    • APA

      Furlan, J. P. R., Castillo, D. F., Stehling, E. G., Sellera, F. P., & Lincopan, N. (2023). The emergence of tet(X) variants highlight challenges for the global genomic surveillance of tigecycline resistance. The Lancet Microbe. London: The Lancet Publishing Group. doi:10.1016/S2666-5247(23)00249-5

    • NLM

      Furlan JPR, Castillo DF, Stehling EG, Sellera FP, Lincopan N. The emergence of tet(X) variants highlight challenges for the global genomic surveillance of tigecycline resistance [Internet]. The Lancet Microbe. 2023 ; 4( 11): e857.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/S2666-5247(23)00249-5

    • Vancouver

      Furlan JPR, Castillo DF, Stehling EG, Sellera FP, Lincopan N. The emergence of tet(X) variants highlight challenges for the global genomic surveillance of tigecycline resistance [Internet]. The Lancet Microbe. 2023 ; 4( 11): e857.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/S2666-5247(23)00249-5

  • Artigo de periodico

    Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions (2022)

    Magalhães, Luísa M. D ; Gollob, Kenneth J; Zingales, Bianca ; Dutra, Walderez O

    Source: The Lancet Microbe. Unidade: IQ

    Subjects: TRYPANOSOMA CRUZI, CARDIOPATIAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MAGALHÃES, Luísa M. D et al. Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions. The Lancet Microbe, v. 3, n. 9, p. e711-e722, 2022Tradução . . Disponível em: https://doi.org/10.1016/S2666-5247(21)00265-2. Acesso em: 27 abr. 2024.

    • APA

      Magalhães, L. M. D., Gollob, K. J., Zingales, B., & Dutra, W. O. (2022). Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions. The Lancet Microbe, 3( 9), e711-e722. doi:10.1016/S2666-5247(21)00265-2

    • NLM

      Magalhães LMD, Gollob KJ, Zingales B, Dutra WO. Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions [Internet]. The Lancet Microbe. 2022 ; 3( 9): e711-e722.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/S2666-5247(21)00265-2

    • Vancouver

      Magalhães LMD, Gollob KJ, Zingales B, Dutra WO. Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions [Internet]. The Lancet Microbe. 2022 ; 3( 9): e711-e722.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1016/S2666-5247(21)00265-2
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024